Transplant success tied to naturally high levels of powerful immune molecule package

April 28 2014

Patients with highest levels of the most powerful version of the immune molecule HLA-G appear to have the lowest risk of rejecting their transplanted kidney, researchers report. Physicians already examine HLA, or human leukocyte antigen, when identifying the best organ donor. When a patient and donor have the same or similar antigens, which are markers for what the body identifies as self and foreign, it increases the chance of a successful transplant.

This is Dr. Laura L. Mulloy, Chief of the MCG Section of Nephrology, Hypertension and Transplantation Medicine and Dr. Anatolij Horuzsko, immunologist both at the Medical College of Georgia at Georgia Regents University.

For more information read the full article here

Recent News

World Kidney Day 2022
March 9 2022
New treatments for COVID-19 - Kidney Care UK seminar
January 30 2022
Christopher dons his running shoes again at 76
December 31 2021
Testing the effectiveness of vaccines in transplant patients
December 30 2021
Booster vaccines - Coming soon!
September 14 2021